Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model
- 1 April 2016
- journal article
- research article
- Published by Springer Nature in Obesity Surgery
- Vol. 26 (11) , 2683-2690
Abstract
Background Roux-en-Y gastric bypass (RYGB) is an effective surgical treatment for type 2 diabetes mellitus (T2DM). The present study aimed to investigate the effects of RYGB on glucose homeostasis, lipid metabolism, and intestinal morphological adaption, as well as hepatic and intestinal gluconeogenesis. Methods Twenty adult male T2DM rats induced by high-fat diet and low dose of streptozotocin were randomly divided into sham and RYGB groups. The parameters of body weight, food intake, glucose tolerance, insulin sensitivity, and serum lipid profiles were assessed to evaluate metabolic changes. Intestinal sections were stained with hematoxylin and eosin (H&E) for light microscopy examination. The messenger RNA (mRNA) and protein expression levels of key regulatory enzymes of gluconeogenesis [phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase)] were determined through reverse-transcription PCR (RT-PCR) and Western blotting, respectively. Results RYGB induced significant improvements in glucose tolerance and insulin sensitivity, along with weight loss and decreased food intake. RYGB also decreased serum triglyceride (TG) and free fatty acid (FFA) levels. The jejunum and ileum exhibited a marked increase in the length and number of intestinal villi after RYGB. The RYGB group exhibited downregulated mRNA and protein expression levels of PEPCK and G6Pase in the liver and upregulated expression of these enzymes in the jejunum and ileum tissues. Conclusions RYGB ameliorates glucose and lipid metabolism accompanied by weight loss and calorie restriction. The small intestine shows hyperplasia and hypertrophy after RYGB. Meanwhile, our study demonstrated that the reduced hepatic gluconeogenesis and increased intestinal gluconeogenesis may contribute to improved glucose homeostasis after RYGB.Keywords
Funding Information
- the Key Project of Shanghai Health and Family Planning Commission (Grant No. 201440026)
This publication has 35 references indexed in Scilit:
- A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal–Jejunal Bypass on Type-2 Diabetes in non-Obese RatsObesity Surgery, 2015
- A gut–brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic healthMolecular Metabolism, 2015
- Changes in Glucose Transporters, Gluconeogenesis, and Circadian Clock after Duodenal–Jejunal Bypass SurgeryObesity Surgery, 2014
- Roux-en-Y Gastric Bypass Surgery or Lifestyle With Intensive Medical Management in Patients With Type 2 DiabetesJAMA Surgery, 2014
- Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgeryThe Lancet Diabetes & Endocrinology, 2014
- Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trialsBMJ, 2013
- Effects of Gastric Bypass Surgery in Patients With Type 2 Diabetes and Only Mild ObesityDiabetes Care, 2012
- Is Intestinal Gluconeogenesis a Key Factor in the Early Changes in Glucose Homeostasis Following Gastric Bypass?Obesity Surgery, 2011
- SAGES guideline for clinical application of laparoscopic bariatric surgerySurgery for Obesity and Related Diseases, 2009
- Intestinal Gluconeogenesis Is a Key Factor for Early Metabolic Changes after Gastric Bypass but Not after Gastric Lap-Band in MiceCell Metabolism, 2008